Our Pricing

Wegovy In Stock UK - Order Today, Delivered Tomorrow

Published on: June 03, 2026

Finding wegovy in stock uk online pharmacy options with reliable availability can be challenging during national shortages. At Cured Pharmacy, we maintain consistent Wegovy stock across all doses, with transparent pricing from £79.00 and next-day delivery across the UK. Every order includes a free clinical assessment by our UK-registered prescribers, ensuring you receive genuine MHRA-licensed medication safely and discreetly.

How Wegovy (Semaglutide) Works for Weight Loss

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone your body produces after eating [1]. This medication works by slowing gastric emptying, reducing appetite signals to the brain, and improving insulin sensitivity — a three-pronged approach that makes sustained weight loss more achievable than diet and exercise alone.

In the landmark STEP 1 clinical trial, participants using Wegovy achieved an average 14.9% body weight reduction over 68 weeks, compared to 2.4% with placebo [1]. These results led to MHRA approval and NICE guidance recommending semaglutide for weight management in adults with a BMI of 30 kg/m² or above, or 27 kg/m² with weight-related health conditions [2].

The once-weekly injection schedule offers significant convenience compared to daily medications. Wegovy pens come pre-filled with precise doses, requiring no mixing or preparation — simply inject subcutaneously into your abdomen, thigh, or upper arm on the same day each week.

Wegovy Dosing Schedule and What to Expect

Wegovy follows a carefully designed dose escalation protocol to minimise gastrointestinal side effects whilst your body adjusts to the medication. You'll start with 0.25mg weekly for four weeks, then gradually increase through 0.5mg, 1mg, and 1.7mg doses before reaching the maintenance dose of 2.4mg [3].

This graduated approach significantly reduces the likelihood of nausea, vomiting, and diarrhoea — the most commonly reported side effects during initial treatment. Clinical experience shows that patients who follow the escalation schedule properly have much better tolerability and adherence rates.

Most patients begin noticing appetite reduction within the first two weeks, though significant weight loss typically becomes apparent after 8-12 weeks of treatment. Your UK prescriber will monitor your progress and may adjust the escalation timeline if you experience persistent side effects.

Managing Side Effects During Dose Escalation

Mild nausea is common during the first few weeks but usually subsides as your body adapts. Eating smaller, more frequent meals and avoiding high-fat foods can help manage gastrointestinal symptoms. If side effects persist beyond the adjustment period, your prescriber may recommend staying at your current dose for an additional week before escalating further.

Wegovy vs Mounjaro: Comparing the Two Leading Injectable Weight Loss Treatments

Both Wegovy and Mounjaro are once-weekly injectable medications licensed by the MHRA for weight management, but they work through different mechanisms. Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist available in the UK [4].

Head-to-head trials suggest tirzepatide may produce slightly greater weight loss outcomes, with the highest dose achieving average reductions of 22.5% body weight in the SURPASS-3 trial compared to 14.9% with semaglutide in STEP 1 [1][4]. However, individual response varies considerably, and factors like tolerability, cost, and personal medical history often matter more than population averages.

At Cured Pharmacy, Wegovy starts from £79.00 whilst Mounjaro begins at £79.00. Both medications require the same commitment to dietary changes and increased physical activity to achieve optimal results. Your UK prescriber will assess which treatment aligns best with your medical history, weight loss goals, and budget during your free consultation.

Which Treatment Is Right for You?

Patients with previous GLP-1 experience may respond better to the dual-action mechanism of Mounjaro, whilst those new to injectable weight loss medications often start with Wegovy due to its extensive clinical data and lower cost. Neither option is inherently superior — the right choice depends on your individual circumstances and prescriber recommendation.

Wegovy Stock Availability and UK Supply Situation

The UK has experienced intermittent Wegovy supply constraints since late 2023 due to unprecedented global demand. Many pharmacies struggle to maintain consistent stock across all doses, particularly the starter pens (0.25mg and 0.5mg) and maintenance dose (2.4mg).

At Cured Pharmacy, we work directly with licensed UK wholesalers and maintain robust stock management systems to ensure availability across the full dose range. Our transparent pricing model means you'll see the exact cost before starting your consultation — no hidden fees or price increases when stock is limited.

We update stock levels in real-time on our website, and our clinical team proactively contacts patients approaching their next dose to ensure continuity of treatment. If a specific dose becomes temporarily unavailable, we'll work with your prescriber to arrange suitable alternatives or notify you immediately when stock returns.

How to Order Wegovy from Cured Pharmacy

Ordering Wegovy through Cured Pharmacy takes under three minutes. Start by completing our free online consultation, which covers your medical history, current medications, weight loss goals, and any contraindications. This assessment is reviewed by a UK-registered prescriber — never an algorithm or overseas clinician.

If Wegovy is deemed clinically appropriate, your prescriber will issue a prescription and our GPhC-registered pharmacy team will dispense your medication the same day for next-day delivery. All orders arrive in completely discreet packaging with no external branding or indication of contents.

We provide clear injection instructions, disposal guidance for used pens, and ongoing support from our clinical team throughout your treatment journey. You can contact our pharmacists directly on (+44) 116 4646009 if you have questions about administration, side effects, or dose progression.

Prescription Requirements and Clinical Assessment

Wegovy is a prescription-only medication in the UK and cannot be supplied without prescriber approval. Our consultation process ensures you meet NICE eligibility criteria and have no contraindications such as personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease [2][3].

Wegovy Pricing and Long-Term Treatment Costs

Wegovy pricing at Cured Pharmacy starts from £79.00 with the exact cost determined by your prescribed dose. We guarantee the lowest prices in the UK and display all costs upfront before you complete your consultation — no surprise fees or subscription lock-ins.

Most patients require 6-12 months of treatment to achieve their target weight loss, though some continue longer for weight maintenance. The dose escalation phase spans approximately 16-20 weeks before reaching the 2.4mg maintenance dose, and clinical trials show that discontinuing treatment often leads to weight regain [1].

Unlike some online pharmacies that bundle consultations into subscription models with cancellation fees, Cured Pharmacy charges only for the medication itself. Your initial prescriber consultation is completely free, and follow-up assessments are included at no additional cost. This transparent approach ensures you understand the true long-term investment before starting treatment.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
3. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Novo Nordisk Limited. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
4. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is indicated for weight management in adults with a BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities, alongside a reduced-calorie diet and increased physical activity.